Metabolic Pathway Research · GLP-1 receptor agonist

EcnoglutideInvestigational GLP-1 receptor agonist.

A GLP-1 receptor agonist in clinical development for incretin pathway research.

Also known as XW003.

4 papers·Clinical development·COA Unverified·0 saved

Scientific name

Investigational GLP-1 receptor agonist.

Scientific Details

Quick Facts

GLP-1 receptor

Mechanism of Action

GLP-1 receptor agonism

Appetite regulation

Glycemic control

Key Pathways

Incretin signaling

Metabolic regulation

Scientific Research

Year	Title / Journal	Type	Cites
2025	Ji 2025 — Ecnoglutide for Overweight or Obesity The Lancet Diabetes & Endocrinology	RCT	17
2024	Zhu 2024 — Ecnoglutide Phase 2 in Type 2 Diabetes The Lancet Diabetes & Endocrinology	RCT	23
2024	Zhu 2024 - Ecnoglutide Phase 2 Trial in Type 2 Diabetes Nature Communications	RCT	23
2023	Guo 2023 - Discovery of Ecnoglutide, a Long-Acting Biased GLP-1 Analog Molecular Metabolism	Preclinical	54

Showing 4 of 4 papers

Regulatory Status

USResearch only

EUNot approved

UKResearch only

AUResearch only

Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.